Studying An Investigational Drug Crizotinib (PF-02341066) In Non Non-Small Cell Lung Cancer Tumors That Are Positive For Anaplastic Lymphoma Kinase (ALK)

National Taiwan University Hospital, Department of Internal Medicine, Taipei

Centro di Ricerca di Fase 1 ASST-Monza, Monza

PO San Gerardo, ASST Monza-U.O Ematologia, Monza

Greenville Health System, Institute for Translational Oncology Research, Greenville

Washington University School of Medicine, St Louis

Highlands Oncology Group, Fayetteville

Highlands Oncology Group, Rogers

Highland Oncology Group, Springdale

Comprehensive Cancer Centers of Nevada, Las Vegas

OHSU Center for Health and Healing 2, Portland

Oregon Health & Science University, Portland

Oregon Health and Science University, Portland

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing

"GBOU VPO First Saint-Petersburg State Medical University n.a.I.P Pavlov Ministry of Health", Saint Petersburg

Institute of Pedriatric Oncology, Hematology and Transplantation n.a R.M Gorbacheva, Saint Petersburg

SUN Yat-Sen University Cancer Center, Guangzhou

National Hospital Organization Nagoya Medical Center, Nagoya

National Cancer Center Hospital, Chuo-ku

National Hospital Organization Kyushu Cancer Center, Fukuoka

Seoul National University Hospital, Seoul

Samsung Medical Center, Seoul